Clinical Trials Browser

Phase 2 × Recruiting × Sirtuins × Clear all

NCT06904196 2025-04-29

Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCC

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05992584 2023-09-14

Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular